In the process of manufacturing pharmaceutical compounds, copious amounts of water are consumed. These waters are used for washing solid cakes, extraction, and equipment. The presence of pharmaceutical compounds in the drinking water is attributed to these processes as well as to common uses of the compounds in farm and urban wastewaters. This is why pharmaceutical wastewater treatment has to be done with great care to prevent illegal discharge.
The pharmaceutical industry recognizes the negative impacts of contaminated water and is committed to protecting the environment and following all regulations. Using generic treatment methods is not suitable for pharmaceutical waste because it’s typically mixed with other waste. Moreover, each pharmaceutical facility produces different types of waste, with varied characteristics including BOD and specific drug residues. Therefore, it is vital to use treatment methods aimed specifically at these types of waste. The advantages of adopting in-house water treatment solutions for pharmaceutical wastewater include reduced costs, increased efficiency, and reduced volume of discarded waste at POTW.
Jiangsu Peier Membrane Corp., ltd provides various Membrane bioreactor (MBR) process solutions for different pharmaceutical companies.
Qilu Pharmaceutical Co., Ltd, the wastewater sources mainly from chemical synthesis production with the main components of pollutants including dichloromethane, chloroform, toluene, triethylamine, acetonitrile, isopropanol, DMF, etc. The process of Peier Membrane’s MBR is more efficient than the traditional method. It helps them save about 650 square meters of land!
Zhejiang Zhebang Pharmaceutical Co., Ltd. is mainly engaged in the production and sales of cephalosporin APIs and pharmaceutical intermediates. At present, the company produces 700 tons of production wastewater every day, including high ammonia nitrogen wastewater, high salt wastewater, high COD wastewater, antibiotic wastewater and other pharmaceutical wastewater. The project originally adopted traditional process, but later it was transformed into Peier Membrane’s MBR process because it could not meet the productivity and effluent quality, which solved the problem of frequent pollution and blockage.
Abuot Jiangsu Peier membrane
Jiangsu Peier membrane corp.,Ltd(Stock Code: 836744) was established in 2007 with a registered capital of 48 million Yuan, referred to as “Peier membrane industry”.
It is a high-tech enterprise focusing on the R&D, production, manufacturing and service of MBR flat sheet membrane products. Its Peier Product category as below:
- Flat Sheet Membrane Element
- Flat Sheet Membrane Element-Single Nozzle
- Flat Sheet Membrane Element-Double Nozzle
- Flat Sheet Membrane Element-3D Soft Support
- Flat Sheet Membrane Element-Renovated Membrane
- Flat Sheet Membrane Module
- Flat Sheet Membrane Module-Module-Single Nozzle
- Flat Sheet Membrane Module-Module-Double Nozzle
- Flat Sheet Membrane Module-2S(Double Deck)
- Flat Sheet Membrane Module-3S(High Flux)
- Flat Sheet Membrane Module-Mini Module
- MBR System
- MBR System-Laboratory Test Equipment
- MBR System-Pilot Equipment
- MBR System-Package System
Peier membrane always adheres to R&D and cooperation with well-known universities at home and abroad, such as Tsinghua University, Sydney University, Nanjing University of technology, Changzhou University and Jiangnan University.
It is the editor in chief of the national industry standard HY/T252-2018 “submerged flat membrane element for water treatment”.
At present, it has 6 invention patents, 46 new utility patents, 1 appearance patent and 4 software works.
